| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25021-615-51 | 25021-615 | HUMAN PRESCRIPTION DRUG | Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride | dexmedetomidine hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20240215 | N/A | ANDA | ANDA217308 | Sagent Pharmaceuticals | DEXMEDETOMIDINE HYDROCHLORIDE | 4 ug/mL | 10 BOTTLE in 1 CARTON (25021-615-51) / 100 mL in 1 BOTTLE |
| 25021-615-50 | 25021-615 | HUMAN PRESCRIPTION DRUG | Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride | dexmedetomidine hydrochloride | INJECTION, SOLUTION | INTRAVENOUS | 20240215 | N/A | ANDA | ANDA217308 | Sagent Pharmaceuticals | DEXMEDETOMIDINE HYDROCHLORIDE | 4 ug/mL | 10 BOTTLE in 1 CARTON (25021-615-50) / 50 mL in 1 BOTTLE |